BioCrossroads releases 2016 annual report

April 27, 2017

For the biotech sector, national and even global forces drive constant change for business models, product approvals and investments, and ultimately, innovation, but Indiana’s life sciences industry maintained its strong leadership position in 2016 with an outsized number of employees, companies and exports.

The economic impact of pharmaceutical, medical device and equipment, agbiosciences, research, testing and medical laboratories and biologistics climbed to $63 billion – a result of more than 56,000 employees and nearly 1,700 companies exporting nearly $10 billion in products, the second highest in the U.S.